This Article Free Full Text Free Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fuhrman, J. Articles by Hansen, L. A. Search for Related Content PubMed PubMed Citation Articles by Fuhrman, J. Articles by Hansen, L. A. Social Bookmarking                         What's this?

Mechanisms of SEPA 0009-Induced Tumorigenesis in v-ras^Ha Transgenic Tg.AC Mice

¹ Department of Biomedical Sciences, Creighton University, Omaha, Nebraska 68178, USA
² MacroChem Corporation, Lexington, Massachusetts 02421, USA

Correspondence: Address correspondence to: Laura A. Hansen, Creighton University, Department of Biomedical Sciences, Criss II/Room 431, 723 N. 18th St., Omaha, Nebraska 68178, USA; e-mail:lhansen{at}creighton.edu

Genetically engineered mouse models with altered oncogene or tumor suppressor gene activity have been utilized recently for carcinogen identification. The v-ras^Ha transgenic Tg.AC mouse, with its enhanced susceptibility to skin tumorigenesis, is thought to be well suited for examining the carcinogenicity of topically applied agents. Tg.AC mice were used to examine the carcinogenicity of SEPA 0009, a rationally designed organic molecule designed to enhance drug penetration through the skin. Fifty mg SEPA 0009/kg body weight, 1500 mg SEPA 0009/kg body weight, or the vehicle alone was applied daily to the skin of Tg.AC mice. Nontransgenic FVB/N mice were also treated with the vehicle alone or 1500 mg SEPA 0009. Daily application of a high-dose of SEPA 0009 caused severe and chronic irritation by 1 week that was maintained throughout the experiment. The irritation was accompanied by increased proliferation, increased apoptosis, and expression of the wound-associated keratin 6. High-dose SEPA 0009 induced squamous papillomas in Tg.AC, but not in nontransgenic mice, by 6 weeks. In mice treated with the high dose SEPA 0009, transgene expression was detected in papillomas at week 9, well after the onset of skin irritation and hyperplasia. In contrast, low-dose SEPA 0009 was not irritating to the skin and did not induce papillomas. Thus, SEPA 0009-induced tumorigenesis was associated with chronic and severe irritation. We propose that SEPA 0009-induced tumorigenesis in Tg.AC mice proceeds through an indirect mechanism that is secondary to cutaneous irritation.

Key Words: SEPA 0009 • v-ras^Ha transgenic Tg.AC mice • skin tumorigenesis • irritation • squamous papillomas

Abbreviations: TPA, Tetradecanoyl phorbol-13-acetate • DMBA, 7, 12-dimethylbenz[a]anthracene • MNNG, 1-methyl-3-nitro-1-nitrosoguanidine • RT, Reverse transcription • TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin

Toxicologic Pathology, Vol. 33, No. 6, 623-630 (2005)
DOI: 10.1080/01926230500278975


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?